New antithrombotic and antiplatelet treatment.
نویسنده
چکیده
Thrombosis is the key pathological process in both unstable angina and acute myocardial infarction (MI). Treatment directed against the thrombus may consist of thrombolysis by plasminogen activators, thrombin inhibition, or platelet inhibition. Data from the TIMI IIIA and IIIB trials have shown conclusively that in contrast to their proven benefits in acute MI, plasminogen activators make the prognosis worse in unstable angina. Thrombolytic treatment is therefore contraindicated in unstable angina, but new types of antithrombotic and antiplatelet agents now oVer alternatives to heparin and aspirin.
منابع مشابه
New antithrombotic drugs.
Thrombosis, both venous and arterial, is a major cause of morbidity and mortality worldwide. Consequently, there is an ongoing search for new antithrombotic drugs, particularly novel antiplatelet agents and anticoagulants. A better understanding of the biochemical pathways involved in platelet activation and coagulation and of the links between these systems and the impact of thrombosis on infl...
متن کاملDual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Dual antiplatelet therapy is currently recommended for all patients with acute coronary syndromes, independent of whether they receive pharmacological treatment or undergo percutaneous coronary intervention. Antiplatelet agents are the cornerstone of pharmacological treatment in interventional cardiology. However, there is a clear need for randomized trials to assess the treatment strategy of d...
متن کاملAnalysis of antithrombotic therapy in elderly patients with atrial fibrillation.
This study aimed to analyze the impact factors and outcome of antithrombotic therapy in elderly patients over 65 years old that suffered from atrial fibrillation (AF). A total of 256 elderly patients with AF over 65 years old were divided into 3 groups: 65-74 years old (N = 86), 75-84 years old (N = 122), and over 85 years old (N = 48). The clinical characteristics, antithrombotic therapy, and ...
متن کاملAntithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
BACKGROUND AND PURPOSE Patients who survive intracerebral hemorrhage (ICH) often have compelling indications for anticoagulant and antiplatelet medication. This nationwide observational study aimed to determine the extent and predictors of antithrombotic treatment after ICH in Sweden. METHODS Patients with a first-ever ICH in the Swedish Stroke Register (Riksstroke) 2005 to 2012 who survived ...
متن کاملManagement of antithrombotic therapies in patients scheduled for eye surgery.
The large majority of patients undergoing ophthalmic surgery are elderly and take systemic medications on a regular basis, including antiplatelet and anticoagulant treatments. It is current practice for many physicians to discontinue antithrombotic treatment prior to surgery to reduce bleeding complications that may lead to retrobulbar haemorrhage and, ultimately, to loss of vision. However, di...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Heart
دوره 82 Suppl 1 شماره
صفحات -
تاریخ انتشار 1999